Humacyte, Inc. — Director's Dealing 2024

Sep 3, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Humacyte, Inc. (HUMA)
CIK: 0001818382
Period of Report: 2024-08-29

Reporting Person: Niklason Laura E (Director, President, CEO and Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-29	Common Stock	P	1222	$6.545	Acquired	242054	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1148240	Indirect
Common Stock	510161	Indirect
Common Stock	3677262	Indirect

Footnotes

F1: This purchase is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person's spouse, of 809,786 shares of the Issuer's common stock on May 31, 2024. The Reporting Person has paid the Issuer $3,391.05, representing the full amount of profit realized in connection with this purchase.